Ana R.
Araújo
abc,
Sergio
Camero†
ab,
Pablo
Taboada
d,
Rui L.
Reis
abc and
Ricardo A.
Pires
*abc
a3B's Research Group, I3Bs – Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal. E-mail: rpires@i3bs.uminho.pt
bICVS/3B's – PT Government Associate Laboratory, Braga/Guimarães, Portugal
cThe Discoveries Centre for Regenerative and Precision Medicine, Headquarters at University of Minho, Avepark, 4805-017 Barco, Guimarães, Portugal
dColloids and Polymers Physics Group, Department of Condensed Matter Physics, Faculty of Physics, University of Santiago de Compostela, Campus Vida, E-15782-Santiago de Compostela, Spain
First published on 17th March 2021
Correction for ‘Vescalagin and castalagin reduce the toxicity of amyloid-beta42 oligomers through the remodelling of its secondary structure’ by Ana R. Araújo et al., Chem. Commun., 2020, 56, 3187–3190, DOI: 10.1039/D0CC00192A.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
Footnote |
† Present address: Institute of Physical Chemistry “Rocasolano”, Spanish National Research Council, Serrano 119, 28006 Madrid, Spain. |
This journal is © The Royal Society of Chemistry 2021 |